Published in Br J Pharmacol on June 01, 1979
Prophylactic lignocaine and early post-coronary artery occlusion dysrhythmias in anaesthetized greyhounds. Br J Pharmacol (1980) 1.10
The beneficial actions of bepridil in acute myocardial infarction in anaesthetized dogs. Br J Pharmacol (1981) 0.90
Lidoflazine in the early stages of acute myocardial ischaemia. Br J Pharmacol (1982) 0.78
Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts. Br J Pharmacol (1991) 0.77
Proceedings of the British Pharmacological Society, University of Cambridge, 6th-8th April, 1983. Abstracts. Br J Pharmacol (1983) 0.75
Effects of blockade of fast and slow inward current channels on ventricular fibrillation in the pig heart. Heart (1996) 0.75
The effect of exaprolol (MG 8823) on epicardial ST-segment changes in a feline model of acute myocardial ischaemia. Br J Pharmacol (1983) 0.75
Factors influencing infarct size following experimental coronary artery occlusions. Circulation (1971) 7.04
Premature mortality from coronary heart disease. The Framingham study. JAMA (1971) 3.15
The effect of hypercapnia on myocardial blood flow and metabolism. J Physiol (1970) 2.26
A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINE. Br J Pharmacol Chemother (1963) 2.24
Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation. Br J Pharmacol (1975) 1.91
Changes in blood flow and oxygen consumption in normal and ischaemic regions of the myocardium following acute coronary artery ligation. Cardiovasc Res (1974) 1.77
Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res (1972) 1.58
Excitatory factors in ventricular tachycardia resulting from myocardial ischemia; potassium a major excitant. Science (1954) 1.41
Relation between infarct size and ventricular arrhythmia. Br Heart J (1975) 1.41
Effects of verapamil on infarct size following experimental coronary occlusion. Cardiovasc Res (1975) 1.32
Acute termination of cardiac arrhythmias with intravenous disopyramide. J Int Med Res (1976) 1.31
Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle. Eur J Pharmacol (1978) 1.25
Ventricular arrhythmias and K+ transfer during myocardial ischemia and intervention with procaine amide, insulin, or glucose solution. J Clin Invest (1967) 1.20
Pharmacology of a new antiarrhythmic agent, gamma-diisopropyl-amino-alpha-phenyl-alpha-(2-pyridyl)-butyramide (SC-7031). J Pharmacol Exp Ther (1962) 1.18
Relationship between epicardial S-T segment changes and myocardial metabolism during acute coronary insufficiency. Circ Res (1973) 1.14
Cardiac effects of disopyramide. Am Heart J (1976) 1.10
ST-segment potentials and mapping. Theory and experiments. Circulation (1976) 1.08
Arteriovenous potassium changes and ventricular arrhythmias after coronary artery occlusion. Cardiovasc Res (1970) 1.05
Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology. Drugs (1973) 1.03
Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate. Am Heart J (1972) 0.99
Effects of various agents on regional ischemic myocardial injury: electrocardiographic analysis. Am Heart J (1974) 0.93
Evidence that serum potassium is not the etiological agent in ventricular fibrillation following coronary artery occlusion. Am Heart J (1960) 0.92
The antidysrhythmic aminosteroid, ORG 6001, reduces the ST-segment elevation produced by coronary occlusion in the dog. Br J Pharmacol (1977) 0.92
Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction. J Int Med Res (1976) 0.86
Haemodynamic effects of intravenous disopyramide in heart failure. Eur J Clin Pharmacol (1975) 0.85
Clinical interpretation of arterial oxygen measurements. Med Clin North Am (1970) 0.82
Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction. J Pharmacol Exp Ther (1976) 0.80
Disopyramide--a review. Scott Med J (1977) 0.79
Reduction of ischemic myocardial damage in the dog by lidocaine infusion. Am J Pathol (1977) 0.78
Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. Br J Pharmacol (1972) 4.53
Increased risk of sepsis after splenectomy. BMJ (1993) 4.26
Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Methods (1980) 3.10
Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol (1990) 2.83
Screening of urines with dipstrips: does it reduce workload and consumable costs? J Clin Pathol (1990) 2.68
Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines. Br J Pharmacol (1973) 2.62
Mapping disease and mortality rates using empirical Bayes estimators. J R Stat Soc Ser C Appl Stat (1991) 2.57
Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase products. Cardiovasc Res (1990) 2.51
The effect of hypercapnia on myocardial blood flow and metabolism. J Physiol (1970) 2.26
Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemia. Vox Sang (2011) 2.08
Proceedings: Comparison of a coronary vasodilator drug (carbochromen) and a cardiac stimulant (oxyfedrin) on blood flow and oxygen extraction in experimental myocardial infarcts. Br J Pharmacol (1972) 1.94
Theatre over-shoes do not reduce operating theatre floor bacterial counts. J Hosp Infect (1991) 1.92
Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation. Br J Pharmacol (1975) 1.91
Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res (1992) 1.86
Changes in blood flow and oxygen consumption in normal and ischaemic regions of the myocardium following acute coronary artery ligation. Cardiovasc Res (1974) 1.77
The effect of indomethacin on the cardiovascular and metabolic responses to E. coli endotoxin in the cat. Br J Pharmacol (1974) 1.63
Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures. J Hosp Infect (1997) 1.60
The antiarrhythmic effect of ischaemic preconditioning in isolated rat heart involves a pertussis toxin sensitive mechanism. Cardiovasc Res (1993) 1.57
Vasospastic elements in myocardial infarction following coronary occlusion in the dog. Cardiovasc Res (1968) 1.55
Myocardial vascular reactivity after beta-adrenergic blockade. Lancet (1966) 1.55
Haemodynamic and myocardial effects of hyperbaric oxygen in dogs subjected to haemorrhage. Cardiovasc Res (1971) 1.54
Naloxone inhibits early arrhythmias resulting from acute coronary ligation. Br J Pharmacol (1982) 1.53
Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature (1981) 1.53
Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun (1990) 1.53
Spontaneous and diffuse coronary artery spasm unresponsive to conventional intracoronary pharmacological therapy: a case report. Catheter Cardiovasc Interv (2000) 1.48
A species comparison of the effects of changing perfusion pressure on blood flow and metabolic heat production in the myocardium. J Physiol (1966) 1.46
Drug-induced changes in blood flow in the acutley ischaemic canine myocardium;relationship to subendocardial driving pressure. Clin Exp Pharmacol Physiol (1975) 1.45
Hypothesis testing in the polychotomous logistic model with an application to detecting gastrointestinal cancer. Stat Med (1985) 1.44
Comparison of the autonomic effects of some currently-used neuromuscular blocking agents [proceedings]. Br J Pharmacol (1979) 1.42
Studies on the mode of action of hexobendine, a prospective anti-anginal drug. Br J Pharmacol (1969) 1.39
Restrictive workplace smoking policies: impact on nonsmokers' tobacco exposure. J Public Health Policy (1992) 1.36
Vehicle interior interactions and kinematics of rear facing child restraints in frontal crashes. Annu Proc Assoc Adv Automot Med (2005) 1.36
A comparison of the beta-adrenoreceptor stimulant properties of isoprenaline, with those of orciprenaline, salbutamol, soterenol and trimetoquinol on isolated atria and trachea of the guinea pig. J Pharm Pharmacol (1970) 1.34
Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium. J Clin Pathol (1984) 1.34
The effect of "selective" beta-adrenoceptor blocking drugs on the myocardial circulation. Br J Pharmacol (1970) 1.31
Drug-induced changes in blood flow in normal and ischaemic regions of the canine myocardium. Br J Pharmacol (1973) 1.31
The effects of carbochromen on myocardial blood flow and metabolic heat production before and after acute coronary ligation. Br J Pharmacol (1969) 1.27
Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle. Eur J Pharmacol (1978) 1.25
Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat. Br J Pharmacol (1981) 1.24
Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis. Br J Surg (1985) 1.23
The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol (1991) 1.23
Pharmacological aspects of the coronary circulation. Prog Med Chem (1969) 1.23
The possible roles of histamine, 5-hydroxytryptamine and prostaglandin F2alpha as mediators of the acute pulmonary effects of endotoxin. Br J Pharmacol (1977) 1.23
Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia. Br J Pharmacol (1983) 1.21
Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br J Pharmacol (1991) 1.21
Measurement of urinary lipopolysaccharide antibodies by ELISA as a screen for urinary tract infection. J Clin Pathol (1991) 1.18
Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology (1988) 1.17
The effects of amyl nitrite inhalation on myocardial blood flow and metabolic heat production. Br J Pharmacol Chemother (1967) 1.17
The effect oa a new anti-inflammatory drug, flurbiprofen, on the respiratory, haemodynamic and metabolic responses to E. coli endotoxin shock in the cat. Br J Pharmacol (1976) 1.16
Suppression by orally-administered nifedipine, nisoldipine and niludipine of early, life-threatening ventricular arrhythmias resulting from acute myocardial ischaemia. Br J Pharmacol (1981) 1.15
The effects of prolonged oral administration of a new antidysrhythmic drug (Org 6001) on coronary artery ligation dysrhythmias in conscious and anesthetized rats. J Cardiovasc Pharmacol (1980) 1.14
The effects of prostaglandins E2, F2 alpha, prostacyclin, flurbiprofen and aspirin on arrhythmias resulting from coronary artery ligation in anaesthetized rats. Br J Pharmacol (1981) 1.13
Television in general practice: the role of a department of medical illustration. J Audiov Media Med (1979) 1.13
Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res (1991) 1.12
Adrenergic receptors in the coronary circulation. Am Heart J (1967) 1.12
Comparative effects of glyceryl trinitrate on venous and arterial smooth muscle in vitro; relevance to antianginal activity. Br J Pharmacol (1977) 1.12
Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs. Br J Pharmacol (1981) 1.11
Prophylactic lignocaine and early post-coronary artery occlusion dysrhythmias in anaesthetized greyhounds. Br J Pharmacol (1980) 1.10
Enzymes in normally perfused and ischaemic dog hearts which release a substance with kinin like activity. Cardiovasc Res (1989) 1.09
Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol (1991) 1.09
Myocardial and haemodynamic effects of phentolamine. Br J Pharmacol (1971) 1.08
The effect of adrenaline, noradrenaline, and propranolol on myocardial blood flow and metabolic heat production in monkeys and baboons. Cardiovasc Res (1969) 1.07
The effects of dopamine and dobutamine on isolated coronary vascular smooth muscle of the pig [proceedings]. Br J Pharmacol (1977) 1.06
Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats. Br J Pharmacol (1984) 1.05
The effect of noradrenaline on blood flow and oxygen consumption in normal and ischemic areas of myocardium. Am Heart J (1973) 1.05
Calcium antagonists prevent early post-infarction ventricular fibrillation. Eur J Pharmacol (1981) 1.04
Prostacyclin--antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK36374 during coronary artery occlusion and reperfusion in anaesthetised greyhounds. J Cardiovasc Pharmacol (1983) 1.04
An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents. Br J Pharmacol (1984) 1.04
The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats. Br J Pharmacol (1970) 1.04
Influence of blood gases, Ca2+-entry blockade and angiotensin converting enzyme inhibition on pressor responses to alpha-adrenoceptor agonists: evidence in vivo for subtypes of response independent of receptor subtype? Clin Sci (Lond) (1985) 1.03
Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol (1994) 1.03
Reduction in ventricular arrhythmias following acute coronary artery ligation in the dog after the administration of creatine phosphate. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.03
The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent. Br J Pharmacol (1977) 1.02
The effect of beta-adrenoceptor blocking agents, with differing ancillary properties, on the arrhythmias resulting from acute coronary artery ligation in anaesthetized rats. Br J Pharmacol (1983) 1.02
Stereospecific antiarrhythmic effect of opioid receptor antagonists in myocardial ischaemia. Br J Pharmacol (1986) 1.01
Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs. Br J Pharmacol (1993) 1.01
Exposure to environmental tobacco smoke in naturalistic settings. Am J Public Health (1992) 1.01
The effect of surgical theatre head-gear on air bacterial counts. J Hosp Infect (1991) 1.00
A comparison of the beta-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline. J Pharm Pharmacol (1970) 1.00
Pharmacological approaches to the therapy of angina. Adv Drug Res (1974) 1.00
Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction. Br J Pharmacol (1976) 0.99
Haemodynamic and coronary effects of quazodine in cats with developing myocardial infarcts. J Pharm Pharmacol (1972) 0.99
Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine. J Cardiovasc Pharmacol (1985) 0.98
Correlation between the effects of salbutamol on contractions and cyclic AMP content of isolated fast-and slow-contracting muscles of the guinea pig. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.98
Evaluation of API 20 STREP system for identifying Listeria species. J Clin Pathol (1989) 0.98
The protective effect of sodium meclofenamate in experimental endotoxin shock. Br J Pharmacol (1975) 0.98
AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhythmias in anaesthetized greyhounds. Br J Pharmacol (1985) 0.98
The effects of dipyridamole on coronary post-occlusion hyperaemia and on myocardial vasodilatation induced by systemic hypoxia. Br J Pharmacol (1972) 0.98
The release of prostanoids during the acute pulmonary response to E. coli endotoxin in anaesthetized cats. Br J Pharmacol (1983) 0.98
The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia. Br J Pharmacol (1989) 0.97
A comparison of the effects of locally and systemically administered kinins on coronary blood flow and myocardial metabolism. Br J Pharmacol Chemother (1966) 0.97
Case of the month: computed tomography in the diagnosis of pyrexia of unknown origin. Br J Radiol (1993) 0.97